Xeris Biopharma Holdings Inc (XERS)
3.475
+0.06
(+1.61%)
USD |
NASDAQ |
Dec 24, 13:00
3.40
-0.08
(-2.16%)
After-Hours: 13:59
Xeris Biopharma Holdings Total Assets (Quarterly): 321.10M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 191.55M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 349.43M |
| Shareholders Equity (Quarterly) | -28.32M |
| Debt to Equity Ratio | -8.166 |
| Current Ratio | 1.789 |
| Net Debt Paydown Yield | -2.03% |